169 Programs
-
Data + PerspectivesThe Current and Future Management of Immune Thrombocytopenia — What Happened at ASH 2025?
-
-
C
-
F
-
H
-
C
-
-
H
-
H
+3 more modules
-
-
Second Opinion
Clinical Investigators Provide Perspectives on the Future Role of AKT Inhibition in the Management of Prostate Cancer
-
-
D
-
E
-
P
-
D
-
-
Diabetology for the Medical Oncologist
Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway
-
-
H
-
J
-
M
- +1
-
H
-
-
Oncology Nursing Update
What Is Molecular Residual Disease Analysis and Why Is It Clinically Relevant in Colorectal Cancer?
-
-
C
-
C
-